Quick Answer
Resistant Starch Gut Health Meta-Analysis has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: After the intervention, the ur gut ® group had lower energy (P ® improved GI-specific anxiety (P = 0.01) and sexual subscale of QOL (P Conclusion Compared with placebo, ur gut ® increased dietary fibre intake, improved gut microbiota and gastrointestinal-specific anxiety without negatively impacting sleep, despite no changes observed in faecal and blood biomarkers.
Key Takeaways
- 01After the intervention, the ur gut ® group had lower energy (P ® improved GI-specific anxiety (P = 0.01) and sexual subscale of QOL (P Conclusion Compared with placebo, ur gut ® increased dietary fibre intake, improved gut microbiota and gastrointestinal-specific anxiety without negatively impacting sleep, despite no changes observed in faecal and blood biomarkers. [Yan R (2026)]
- 02Purpose A diet low in FODMAP may negatively affect the gut microbiota of some Irritable Bowel Syndrome (IBS) patients, despite alleviating symptoms. [Yan R (2026)]
- 03This pilot study comprehensively explores the effects of a 3-week ur gut ® supplementation on gut microbiota, gut health, dietary intake, sleep, mental health and quality of life (QOL) in individuals with IBS following a low FODMAP diet. [Yan R (2026)]
- 04This narrative review summarizes current evidence on dietary and supplementation-based strategies for modulating the gut microbiota, with particular attention to dietary fiber, fermented foods, prebiotics, probiotics, synbiotics, and postbiotics. [Ekstedt-Biskot N (2026)]
The current Migaku evidence database contains 2 reusable source documents for Resistant Starch Gut Health Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts.
- After the intervention, the ur gut ® group had lower energy (P ® improved GI-specific anxiety (P = 0.01) and sexual subscale of QOL (P Conclusion Compared with placebo, ur gut ® increased dietary fibre intake, improved gut microbiota and gastrointestinal-specific anxiety without negatively impacting sleep, despite no changes observed in faecal and blood biomarkers. [Yan R (2026); evidence level 2]
- Purpose A diet low in FODMAP may negatively affect the gut microbiota of some Irritable Bowel Syndrome (IBS) patients, despite alleviating symptoms. [Yan R (2026); evidence level 2]
- This pilot study comprehensively explores the effects of a 3-week ur gut ® supplementation on gut microbiota, gut health, dietary intake, sleep, mental health and quality of life (QOL) in individuals with IBS following a low FODMAP diet. [Yan R (2026); evidence level 2]
- This narrative review summarizes current evidence on dietary and supplementation-based strategies for modulating the gut microbiota, with particular attention to dietary fiber, fermented foods, prebiotics, probiotics, synbiotics, and postbiotics. [Ekstedt-Biskot N (2026); evidence level 4]
- Overall, current evidence suggests that microbiota-targeted nutritional strategies may support gut homeostasis and selected health-related outcomes; however, their effects are not universal and require more personalized and better-controlled approaches in future research. [Ekstedt-Biskot N (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources